Future Virology · 2021 · 75 citations · 22 references
Life SciencesInfectious DiseasesMolecular BiologyImmunizationMolecular VirologyVirologyMicrorna BiogenesisMicrorna BiologyRna InterferenceViral InfectionsViral PathogenesisViral Rna BiologyCoronavirus VaccinesMicrorna TargetingMicrorna TherapeuticsSars-cov-2 Antiviral TherapySars-cov-2 InfectionTranslational Regulation By MicrornasTranslational Repression By MicrornasViral Rna Translation
Nowadays, the SARS Coronavirus 2 (SARS-CoV-2) infection is recognized as the primary cause of mortality in humans. SARS-CoV-2 is transmitted through human-to-human contact and is asymptomatic in most patients. In addition to approved vaccines against SARS-CoV-2 infection, miRNAs may also be promising options against this new virus. miRNAs are small and noncoding RNAs 18-25 nucleotides in length that target the mRNAs to degrade them or obstruct their translation miRNAs act as an observer in cells. This study reviewed the literature on the potential role of cellular miRNAs in the SARS-CoV-2-host interplay as a therapeutic option in COVID-19 patients. © 2021 Future Medicine Ltd.. All rights reserved.
22
Circulating inflamma-miRs in aging and age-related diseases
Fabiola Olivieri, Maria Rita Rippo, Antonio Domenico Procopio et al. · Frontiers in Genetics · 2013 · 178 citations · Full text
Md. Abdullah‐Al‐Kamran Khan, Md. Rabi Us Sany, Md. Shafiqul Islam et al. · Frontiers in Genetics · 2020 · 169 citations · Full text